Gemmk: A Phase I Study Of Gemcitabine (Gem) And Pembrolizumab (Pem) In Patients (Pts) With Leiomyosarcoma (Lms) And Undifferentiated Pleomorphic Sarcoma Ups) A. Smrke, A. Ostler, A. Napolitano, M. Vergnano, B. Asare, N. Fotiadis,K. Thway,S. Zaidi, A. B. Miah,W. Van Der Graaf,S. Gennatas,C. Benson,P. H. Huang,R. L. JonesANNALS OF ONCOLOGY（2021）引用 7|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
